Aurelia Private Equity et al. back GILUPI

GILUPI is a developer and producer of medical devices for the in vivo isolation of rare cells from blood circulation. The capital will be used for CE-certification and the market introduction of its patented medical detector. The medical devices will be used in the future for cancer and prenatal diagnostics. The Potsdam-based company was founded in 2006.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Diana Petrowicz on +44 20 7004 7505 or diana.petrowicz@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Technology
• Early-stage
• High-Tech Gründerfonds